Earth Science Tech (ETST) Net Equity Issued and Repurchased (2012 - 2024)
Earth Science Tech's (ETST) quarterly Net Equity Issued and Repurchased came in at $330.0 in Q1 2024, down 99.87% YoY from $247700.0 in Q2 2023, and down 99.7% on a QoQ basis from $110001.0 in Q2 2023.
Earth Science Tech (ETST) Net Equity Issued and Repurchased (2012 - 2024) Analysis & Trends
Earth Science Tech (ETST) has 11 years of Net Equity Issued and Repurchased data on file, last reported at $330.0 in Q1 2024.
- Quarterly Net Equity Issued and Repurchased fell 99.87% year-over-year to $330.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $110331.0 (down 58.79% YoY) and the FY2024 annual result came in at $110331.0, down 80.44% from the prior year.
- Net Equity Issued and Repurchased retreated to $330.0 in Q1 2024, from $110001.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $247700.0 in Q1 2023 to a low of $330.0 in Q1 2024.
- A 5-year average of $61231.4 and a median of $28175.0 in 2021 frame the typical range for Net Equity Issued and Repurchased.
- Annual changes were most pronounced in 2023 — Net Equity Issued and Repurchased surged 2377.0% — and 2024, when it tumbled 99.87%.
- Tracing ETST's Net Equity Issued and Repurchased over 5 years: stood at $19932.0 in 2020, then slumped by 49.83% to $10000.0 in 2021, then changed by 0.0% to $10000.0 in 2022, then soared by 1000.01% to $110001.0 in 2023, then sank by 99.7% to $330.0 in 2024.
- The last three Net Equity Issued and Repurchased figures came in at $330.0 (Q1 2024), $110001.0 (Q2 2023), and $247700.0 (Q1 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Earth Science Tech | 32.54 Mn | 29.72 Mn | 6.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 330.00 |
| Mar 31, 2024 | 330.00 |
| Jun 30, 2023 | 110,001.00 |
| Jun 30, 2023 | 110,001.00 |
| Mar 31, 2023 | 247,700.00 |
| Mar 31, 2023 | 247,700.00 |
| Mar 31, 2022 | 10,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Dec 31, 2021 | 10,000.00 |
| Dec 31, 2021 | 10,000.00 |
| Jun 30, 2021 | 28,175.00 |
| Jun 30, 2021 | 28,175.00 |
| Sep 30, 2020 | 19,932.00 |
| Sep 30, 2020 | 19,932.00 |
| Jun 30, 2020 | 40,592.00 |
| Jun 30, 2020 | 40,592.00 |
| Mar 31, 2020 | 84,353.00 |
| Mar 31, 2020 | 84,353.00 |
| Dec 31, 2019 | 42,466.00 |
| Dec 31, 2019 | 42,466.00 |